Search results
Found 14 matches for
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
Oxford Surgical Innovation Conference 2024
Innovation
Friday, 15 March 2024, 8.45am to 5.30pm
A showcase of recent innovations in surgical practice and policy in a hybrid in-person/virtual format, targeted at surgically inclined students, trainees and consultants.